Bath & Body Works (BBWI) director receives 7,970-share stock award

Rhea-AI Filing Summary

Bogliolo Alessandro reported acquisition or exercise transactions in this Form 4 filing.

Bath & Body Works director Alessandro Bogliolo received an equity grant of 7,970 shares of common stock. The award was made on June 11, 2026 as an annual grant of restricted stock units to an independent non-employee director. Following this grant, Bogliolo directly holds 24,490 shares of Bath & Body Works common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Bogliolo Alessandro

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.50 par value	7,970	$0.00	--

Holdings After Transaction: Common Stock, $0.50 par value — 24,490 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Stock award: 7,970 shares Holdings after transaction: 24,490 shares Transaction price: $0.00 per share +1 more

4 metrics

Stock award 7,970 shares Annual restricted stock unit grant to independent director on June 11, 2026

Holdings after transaction 24,490 shares Total Bath & Body Works common stock directly held by Bogliolo after grant

Transaction price $0.00 per share Reported price for the 7,970-share equity award

Security title Common Stock, $0.50 par value Class of Bath & Body Works shares underlying the grant

Key Terms

restricted stock units, independent non-employee directors, Common Stock, $0.50 par value, Form 4

4 terms

restricted stock units financial

"Annual award of restricted stock units to independent non-employee directors."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

independent non-employee directors financial

"Annual award of restricted stock units to independent non-employee directors."

Common Stock, $0.50 par value financial

"Common Stock, $0.50 par value"

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/15/2026 - 04:20 PM Accepted by SEC EDGAR 06/15/2026 - 04:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bogliolo Alessandro

(Last) (First) (Middle)

THREE LIMITED PARKWAY

(Street)

COLUMBUS OHIO 43230

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bath & Body Works, Inc. [ BBWI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.50 par value	06/11/2026		A		7,970(1)	A	$0.0000	24,490	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual award of restricted stock units to independent non-employee directors.

	Robert J. Tannous, Attorney-in-Fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Bath & Body Works (BBWI) report for Alessandro Bogliolo?

Bath & Body Works reported that director Alessandro Bogliolo received an equity grant of 7,970 shares. This was an annual restricted stock unit award for an independent non-employee director, increasing his direct holdings to 24,490 shares of common stock.

How many Bath & Body Works (BBWI) shares did Alessandro Bogliolo receive in this grant?

Alessandro Bogliolo received 7,970 shares of Bath & Body Works common stock. The grant was reported at a price of $0.00 per share, reflecting a stock-based compensation award rather than an open-market purchase transaction.

What are Alessandro Bogliolo’s total Bath & Body Works (BBWI) holdings after the grant?

After the June 11, 2026 grant, Alessandro Bogliolo directly holds 24,490 shares of Bath & Body Works common stock. This total includes the newly awarded 7,970-share annual restricted stock unit grant to the independent non-employee director.

Was the Bath & Body Works (BBWI) insider transaction an open-market buy or a stock award?

The transaction was a stock award, not an open-market purchase. Bath & Body Works granted 7,970 shares to director Alessandro Bogliolo as an annual restricted stock unit award for independent non-employee directors, reported at a transaction price of $0.00 per share.

What does the footnote on the Bath & Body Works (BBWI) Form 4 filing indicate?

The footnote explains that the transaction represents an annual award of restricted stock units to independent non-employee directors. This clarifies that the 7,970-share grant to director Alessandro Bogliolo is routine board compensation rather than a discretionary open-market trade.